Next Generation Capecitabine (NGC) Dosage Regimens Have Been Identified In The Ongoing Phase 1B Trial With Potentially Better Safety And Efficacy Profiles Than Existing Chemotherapy
Richmond Mutual Bancorporation, Inc. Increases Quarterly Dividend From $0.10 To $0.14 Per Share
Richmond Mutual Bancorporation, Inc. (NASDAQ:RMBI) announced today that its Board of Directors has declared a cash dividend on Richmond Mutual Bancorporation common stock of $0.14 per share, which represents